Lijekovi gentamicin, valsartan+ hidroklorotiazid, klozapin, pembrolizumab - iznimna žurnost

Deadline:N/A

Contract award

Estimated value
€2,343,501.72
Bidders
Awarded bidders
Name
OKTAL PHARMA d.o.o.
MEDIKA, d.d.